Drug class
Peptic Ulcer Agents
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders. Read more about Peptic Ulcer Agents
513 drugs in this class 187 manufacturers
Drugs in Peptic Ulcer Agents
FAMOTIDINE
NEXIUM (esomeprazole magnesium)
OMEPRAZOLE
PANTOPRAZOLE SODIUM
FAMOTIDINE
IBUPROFEN-FAMOTIDINE (ibuprofen/famotidine)
OMEPRAZOLE
FAMOTIDINE
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders.
These agents primarily function either by reducing gastric acid production and acidity—via proton pump inhibition, histamine H2-receptor blockade, or chemical neutralization—or by enhancing mucosal cytoprotection and forming physical barriers over damaged tissue.
Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonsteroidal anti-inflammatory drugs.
Additionally, antisecretory members of this class serve as critical components in antimicrobial combination regimens to eradicate *Helicobacter pylori* infections.
-
nih.gov
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders
-
nih.gov
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonsteroidal anti-inflammatory drugs Additionally, antisecretory members...
-
nih.gov
These agents primarily function either by reducing gastric acid production and acidity—via proton pump inhibition, histamine H2-receptor blockade, or chemical neutralization—or by enhancing mucosal cytoprotection and forming physical barriers over damaged tissue Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonster...
-
nih.gov
These agents primarily function either by reducing gastric acid production and acidity—via proton pump inhibition, histamine H2-receptor blockade, or chemical neutralization—or by enhancing mucosal cytoprotection and forming physical barriers over damaged tissue
-
nih.gov
Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonsteroidal anti-inflammatory drugs
-
nih.gov
Additionally, antisecretory members of this class serve as critical components in antimicrobial combination regimens to eradicate *Helicobacter pylori* infections
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.